CLASS II ONGOING Device recall · Reported 23 Apr 2025 · FDA Enforcement Report

Philips DXR System, DuraDiagnost Rel recalled by Philips North America

Philips North America is recalling Philips DXR System, DuraDiagnost Rel, distributed nationwide in the US. The recall was initiated on 10 Mar 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF 712214; UDI: (01)00884838064751(21); Serial No. SN170009, SN170010, SN180072, SN180020 200037, SN160061, SN180075, 200089, SN180045, SN160096.
Quantity recalled83 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1554-2025
FDA event ID
96435
Recalling firm
Philips North America, Cambridge, MA
Classification
Class II
Status
Ongoing
Recall initiated
10 Mar 2025
FDA classified
11 Apr 2025
Reported
23 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

10 Mar 2025Recall initiated by company
11 Apr 2025Classified by FDA+32 days
23 Apr 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for collimator to fall as a result of incorrect installation.

Product as listed by the FDA

Philips DXR System, DuraDiagnost Rel. 4. Stationary X-Ray System.

Where it was distributed

Worldwide - US Nationwide distribution in the states of AK, FL, KS, MS, NH, NY, OR, PA, TX, WI and the countries of Argentina, Australia, Canada, Chile, China, Germany, Hungary, India, Indonesia, Italy, Kenya, Mexico, Netherlands, New Zealand, Oman, Pakistan, Peru, Poland, Romania, Russian Federation, Slovenia, South Africa, Spain, Thailand, United Kingdom, Vietnam.

Nationwide AlaskaFloridaKansasMississippiNew HampshireNew YorkOregonPennsylvaniaTexasWisconsin

Questions about this recall

Why was it recalled?

Potential for collimator to fall as a result of incorrect installation.

Which lots are affected?

REF 712214; UDI: (01)00884838064751(21); Serial No. SN170009, SN170010, SN180072, SN180020 200037, SN160061, SN180075, 200089, SN180045, SN160096.

Where was it sold?

Worldwide - US Nationwide distribution in the states of AK, FL, KS, MS, NH, NY, OR, PA, TX, WI and the countries of Argentina, Australia, Canada, Chile, China, Germany, Hungary, India, Indonesia, Italy, Kenya, Mexico, Netherlands, New Zealand, Oman, Pakistan, Peru, Poland, Romania, Russian Federation, Slovenia, South Africa, Spain, Thailand, United Kingdom, Vietnam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 96435
ReportedClassRecallCompanyReasonWhere
CLASS IIPhilips DXR System, DuraDiagnost recalled by Philips North AmericaPhilips North AmericaOtherNationwide

More recalls from Philips North America

All 558

Other Imaging Equipment recalls

All 2,347